Béatrice de Vos

Chief Tech/Sci/R&D Officer presso DMS IMAGING

Health Technology

Consumer Services

Profilo

Béatrice de Vos is currently the Chief Medical Officer at DMS Imaging SA and a Member at the Belgian College of Pharmaceutical Medicin.
Previously, she served as the Chairman at DMS Imaging SA from 2013 to 2017.
She also held positions as the Regional Director at Wyeth-Ayerst Research from 1992 to 1999, Vice President-Global Medical Affairs at GlaxoSmithKline Biologicals NV from 1999 to 2007, Vice President-Global Medical & Scientific Affairs at Sanofi Pasteur from 2007 to 2010, and Chief Medical Officer at PROMETHERA Biosciences SA from 2011 to 2015.
Dr. de Vos obtained a doctorate degree from the University of Antwerp.

Posizioni attive di Béatrice de Vos

Società	Posizione	Inizio
DMS IMAGING	Chief Tech/Sci/R&D Officer	-
Belgian College of Pharmaceutical Medicin	Corporate Officer/Principal	-

Tutte le posizioni attive di Béatrice de Vos

Precedenti posizioni note di Béatrice de Vos

Società	Posizione	Fine
DMS IMAGING	Chairman	20/03/2017
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.	Chief Tech/Sci/R&D Officer	01/04/2015
Sanofi Pasteur Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.	Chief Tech/Sci/R&D Officer	01/01/2010
GlaxoSmithKline Biologicals NV GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium.	Chief Tech/Sci/R&D Officer	01/01/2007
Wyeth-Ayerst Research	Corporate Officer/Principal	01/01/1999

Vedi nel dettaglio l'esperienza di Béatrice de Vos

Formazione di Béatrice de Vos

University of Antwerp

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Béatrice de Vos

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
DMS IMAGING	Health Technology

Aziende private	4
GlaxoSmithKline Biologicals NV GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium.	Health Technology
Sanofi Pasteur Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.	Health Technology
Wyeth-Ayerst Research
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.	Health Technology

Vedi le connessioni aziendali

Borsa valori
Insiders
Béatrice de Vos